About us
Get to know the EB Research Institute
The aim of our institute is to pioneer innovative approaches to treating Epidermolysis bullosa (EB) - we are dedicated to improving lives of people living with EB by transitioning research and development into novel therapies.
Our dedicated team of scientists, innovators, and industry experts combines cutting-edge knowledge with a shared passion for advancing treatments, working collaboratively to develop solutions that improve lives of people living with EB and shape the future of EB diagnostic and treatment options.
Executive Board
Dr. Hana Cernecka, PharmD
Managing Director EB Research Institute
Dr. Rainer Riedl
Managing Director EB Research Institute | Chairman & Managing Director DEBRA AustriaBiobank
Christina Guttmann-Gruber, PhD
Biobank Manager
Stefan Hainzl, PhD
Biobanking Specialist
Bernadette Liemberger, PhD
Biobanking Specialist
Verena Moos, MSc
Scientific Associate
Research
Marina Barros-Pinkelnig, MSc
Senior Scientific Associate
Johannes Bischof, PhD
Senior Research Scientist
Stefanie Gruner, BSc
Scientific Associate
Natalie Heschl, BSc
Scientific Associate
Markus Hierl, PhD
Research Scientist
Assoc.-Prof. Thomas Kocher, PhD
Senior Research Scientist
Assoc.-Prof. Ulrich Koller, PhD
Principal Investigator
Michael Lew, MSc
Senior Scientific Associate / Bioinformatics
Krisztina Ćtvƶs, PhD
Research Scientist
Josefina PiĆ±Ć³n Hofbauer, PhD
Preclinical Model Specialist
Victoria Reichl, PhD
Senior Research Scientist
Lara Ronacher, BA MSc
Scientific Associate
Lena Schmid, BSc
Scientific Associate
Anshu Sharma, PhD
Senior Research Scientist
Daniela Stoica-Andrei, PhD
PostDoc
Monika Wimmer, PhD
Research Scientist - currently on maternity leave